Evidence map›Paper›PMID 39859388›Full record

ArticleInternational journal of molecular sciences2025

Urokinase Plasminogen Activation System Modulation in Transformed Cell Lines.

Diana Culej Bošnjak, Tihana Balent, Petra Korać, Mariastefania Antica, Maja Matulić

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diana Culej BošnjakDepartment of Biology, Faculty of Science, University of Zagreb, Horvatovac 102, 10000 Zagreb, Croatia.ORCID 0000-0002-5462-6303
Tihana BalentDepartment of Biology, Faculty of Science, University of Zagreb, Horvatovac 102, 10000 Zagreb, Croatia.
Petra KoraćDepartment of Biology, Faculty of Science, University of Zagreb, Horvatovac 102, 10000 Zagreb, Croatia.ORCID 0000-0003-4783-2114
Mariastefania AnticaRuđer Bošković Institute, Bijenička 54, 10000 Zagreb, Croatia.ORCID 0000-0001-8449-1078
Maja MatulićDepartment of Biology, Faculty of Science, University of Zagreb, Horvatovac 102, 10000 Zagreb, Croatia.ORCID 0000-0002-3498-5616

Funding

Croatian Science Foundation IP-2020-02-2431The Terry Fox Foundation and Croatian League Against Cancer as well as the Ministry of Science and Education of the Republic of Croatia and by the Scientific Centre of Excellence for Reproductive and Regenerative Medicine (Grant Agreement KK01.1.1.01.0008 KK01.1.1.01.0008
6 · The paper itself

Abstract

The role of the plasminogen activation system is to regulate the activity of the extracellular protease plasmin. It comprises the urokinase plasminogen activator (uPA), a specific extracellular protease which activates plasminogen, its inhibitor PAI1, and the urokinase plasminogen activator receptor, uPAR, which localizes the urokinase activity. The plasminogen activation system is involved in tissue remodeling through extracellular matrix degradation, and therefore participates in numerous physiological and pathological processes, which make it a potential biomarker. To investigate the role of these molecules in the cellular processes, we cloned human uPA, PAI1, and uPAR and overexpressed them in two cell lines, the glioblastoma line A1235 and the transformed human embryonal kidney cells HEK 293. We analyzed the urokinase activity and the expression of plasminogen activation system elements on the protein and RNA level by Western blot analysis and RTqPCR. Cell proliferation was followed up by cell counting, cell migration and invasion by wound-healing and the transwell assays, respectively, and cell adhesion and dispersal by spheroid formation. The cells transfected with urokinase sequence had increased urokinase activity and uPA expression, while the PAI1-transfected cells decreased urokinase activity, increased PAI1 expression, and decreased cell migration. HEK 293 cells expressing PAI formed only small spheroids. The effects of the uPA system molecules depended on their interactions with each other and with other molecules in the microenvironment, as well as on the cell-type-specific signaling.

Indexed as

PlasminogenUrokinase-Type Plasminogen ActivatorCell AdhesionCell Line, TransformedCell Line, TumorCell MovementCell ProliferationGlioblastomaHEK293 CellsHumansPlasminogen Activator Inhibitor 1Receptors, Urokinase Plasminogen ActivatorPlasminogenPlasminogen Activator Inhibitor 1PLAUR protein, humanReceptors, Urokinase Plasminogen ActivatorSERPINE1 protein, humanUrokinase-Type Plasminogen Activatoradhesionmigrationplasminogen activator inhibitorproliferationurokinase plasminogen activator

Identifiers

PMID39859388
PMCPMC11765620

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.